|Bid||0.0000 x 900|
|Ask||0.0000 x 800|
|Day's Range||1.0400 - 1.0850|
|52 Week Range||1.0100 - 8.7000|
|Beta (5Y Monthly)||0.78|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 15, 2022 - Mar 21, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||5.00|
Cambridge, MA, May 11, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today reports its financial results and provides an update on operational progress for the first quarter ended March 31, 2022. Note: A glossary of terms is included at the end of this document to allow for the ease of understanding of terms or concepts used throughout this release. Financial Highlights Aggregate cash, accounts receivable, and tax credits receivable on March
The big shareholder groups in Summit Therapeutics Inc. ( NASDAQ:SMMT ) have power over the company. Generally speaking...
Over the last year, a good number of insiders have significantly increased their holdings in Summit Therapeutics Inc...